Table 2.
Summary of patients’ characteristics of included studies
| No | Study | Mean age, years | Male gender, % | Baseline SCr, mg/dL | HTN, % | Diabetes, % | Heart failure, % | Sepsis, % | Surgery, % | Disease severity |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Massoth et al. [25] | 72.5 | 73 (73.0%) | 1.0 | 72 (72.0%) | 27 (27.0%) | 33 (33.0%) | Unknown | 100 (100%) | SOFA 10 APACHE 22 |
| 2 | Koyner et al. [24] | 64 | 209 (62.4%) | 1.0 | 228 (68.1%) | 110 (32.8%) | 73 (21.8%) |
75 (22.4%) |
105 (31.3%) | Non-renal APACHE III 54 |
| 3 | Pan et al. [26] | 61.3 | 101 (72.1%) | 1.84 | 72 (51.4%) | 58 (41.4%) | Unknown | 68 (48.6%) | 88 (62.9%) | SOFA 10.8 |
| 4 | Qian et al. [19] | 58 | 102 (62.2%) | 0.74 | 57 (34.8%) | 30 (18.3%) | Unknown | 43 (26.2%) | 112 (68.3%) | Non-renal SOFA 4.8 APACHE II 14.6 |
| 5 | Jiang et al. [18] | 65.5 | 25 (52.1%) | 1.56 | 26 (54.2%) | 13 (27.1%) | Unknown | 48 (100%) | Unknown | SOFA 9 |
| 6 | Meersch et al. [20] | 69.5 | 131 (63.0%) | 1.04 | 142 (68.3%) | 53 (25.5%) | 51 (24.5%) | Unknown | 208 (100%) | SOFA 11.4 APACHE 28.4 |
APACHE, The Acute Physiology and Chronic Health Evaluation; HTN, hypertension; SCr, serum creatinine; SOFA, sequential organ failure assessment